Latest Insider Transactions at Broadridge Financial Solutions, Inc. (BR)
This section provides a real-time view of insider transactions for Broadridge Financial Solutions, Inc. (BR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BROADRIDGE FINANCIAL SOLUTIONS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BROADRIDGE FINANCIAL SOLUTIONS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2024
|
Christopher John Perry President |
SELL
Open market or private sale
|
Direct |
17,534
-25.87%
|
$3,734,742
$213.41 P/Share
|
|
Sep 06
2024
|
Richard J Daly Executive Chairman |
SELL
Open market or private sale
|
Direct |
21,938
-9.02%
|
$4,541,166
$207.66 P/Share
|
|
Sep 06
2024
|
Richard J Daly Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
14,510
+10.25%
|
$1,697,670
$117.34 P/Share
|
|
Aug 26
2024
|
Leslie A Brun Director |
SELL
Open market or private sale
|
Direct |
5,739
-6.91%
|
$1,205,190
$210.05 P/Share
|
|
Aug 26
2024
|
Leslie A Brun Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,445
+10.21%
|
$425,025
$45.09 P/Share
|
|
Aug 23
2024
|
Timothy C Gokey CEO |
SELL
Open market or private sale
|
Direct |
25,000
-10.81%
|
$5,225,000
$209.31 P/Share
|
|
Aug 23
2024
|
Timothy C Gokey CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,674
+11.71%
|
$1,564,374
$51.95 P/Share
|
|
Aug 21
2024
|
Christopher John Perry President |
SELL
Open market or private sale
|
Direct |
6,501
-8.75%
|
$1,365,210
$210.22 P/Share
|
|
Aug 21
2024
|
Christopher John Perry President |
BUY
Exercise of conversion of derivative security
|
Direct |
7,005
+8.62%
|
$1,036,740
$148.07 P/Share
|
|
Aug 19
2024
|
Christopher John Perry President |
SELL
Open market or private sale
|
Direct |
162
-0.24%
|
$34,020
$210.0 P/Share
|
|
Aug 19
2024
|
Christopher John Perry President |
BUY
Exercise of conversion of derivative security
|
Direct |
175
+0.26%
|
$25,900
$148.07 P/Share
|
|
Aug 16
2024
|
Christopher John Perry President |
SELL
Open market or private sale
|
Direct |
300
-0.44%
|
$63,000
$210.0 P/Share
|
|
Aug 16
2024
|
Christopher John Perry President |
BUY
Exercise of conversion of derivative security
|
Direct |
323
+0.48%
|
$47,804
$148.07 P/Share
|
|
Aug 16
2024
|
Timothy C Gokey CEO |
SELL
Open market or private sale
|
Direct |
25,000
-11.08%
|
$5,225,000
$209.11 P/Share
|
|
Aug 16
2024
|
Timothy C Gokey CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,675
+11.97%
|
$1,564,425
$51.95 P/Share
|
|
Aug 15
2024
|
Christopher John Perry President |
SELL
Open market or private sale
|
Direct |
200
-0.3%
|
$42,000
$210.15 P/Share
|
|
Aug 15
2024
|
Christopher John Perry President |
BUY
Exercise of conversion of derivative security
|
Direct |
216
+0.32%
|
$31,968
$148.07 P/Share
|
|
Aug 14
2024
|
Christopher John Perry President |
SELL
Open market or private sale
|
Direct |
31,539
-11.95%
|
$6,528,573
$207.31 P/Share
|
|
Aug 14
2024
|
Christopher John Perry President |
BUY
Exercise of conversion of derivative security
|
Direct |
34,326
+11.52%
|
$4,634,010
$135.62 P/Share
|
|
Aug 13
2024
|
Thomas P Carey Corporate VP |
BUY
Grant, award, or other acquisition
|
Direct |
5,116
+26.11%
|
-
|
|
Aug 13
2024
|
Richard J Daly Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
1,239
+1.09%
|
-
|
|
Aug 13
2024
|
Douglas Richard Deschutter Co-President ICS |
BUY
Grant, award, or other acquisition
|
Direct |
1,782
+5.04%
|
-
|
|
Aug 13
2024
|
Ashima Ghei Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
455
+11.34%
|
-
|
|
Aug 13
2024
|
Timothy C Gokey CEO |
BUY
Grant, award, or other acquisition
|
Direct |
29,381
+13.09%
|
-
|
|
Aug 13
2024
|
Laura Matlin CVP, Deputy GC and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
588
+8.77%
|
-
|
|
Aug 13
2024
|
Christopher John Perry President |
BUY
Grant, award, or other acquisition
|
Direct |
8,139
+11.22%
|
-
|
|
Aug 13
2024
|
Richard John Stingi Corporate VP and CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
1,860
+22.17%
|
-
|
|
Aug 08
2024
|
Laura Matlin CVP, Deputy GC and CCO |
SELL
Open market or private sale
|
Direct |
673
-10.85%
|
$145,368
$216.0 P/Share
|
|
Jul 05
2024
|
Robert N Duelks Director |
BUY
Grant, award, or other acquisition
|
Direct |
77
+0.39%
|
-
|
|
Jul 05
2024
|
Leslie A Brun Director |
BUY
Grant, award, or other acquisition
|
Direct |
110
+0.15%
|
-
|
|
Jul 05
2024
|
Pamela L Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.39%
|
-
|
|
Jul 05
2024
|
Melvin L Flowers Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.35%
|
-
|
|
Jul 05
2024
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
43
+0.19%
|
-
|
|
Jul 05
2024
|
Maura A. Markus Director |
BUY
Grant, award, or other acquisition
|
Direct |
66
+0.13%
|
-
|
|
Jul 05
2024
|
Eileen K Murray Director |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.16%
|
-
|
|
Jul 05
2024
|
Annette L. Nazareth Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.18%
|
-
|
|
Jul 05
2024
|
Amit Zavery Director |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.18%
|
-
|
|
Jun 13
2024
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
144
+1.26%
|
-
|
|
Jun 13
2024
|
Maura A. Markus Director |
BUY
Grant, award, or other acquisition
|
Direct |
163
+0.65%
|
-
|
|
Jun 13
2024
|
Eileen K Murray Director |
BUY
Grant, award, or other acquisition
|
Direct |
144
+6.21%
|
-
|
|
Jun 13
2024
|
Annette L. Nazareth Director |
BUY
Grant, award, or other acquisition
|
Direct |
144
+3.8%
|
-
|
|
Jun 13
2024
|
Amit Zavery Director |
BUY
Grant, award, or other acquisition
|
Direct |
132
+1.96%
|
-
|
|
Jun 05
2024
|
Robert N Duelks Director |
SELL
Open market or private sale
|
Direct |
3,473
-13.33%
|
$687,654
$198.06 P/Share
|
|
Jun 05
2024
|
Robert N Duelks Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,469
+19.89%
|
$291,105
$45.09 P/Share
|
|
May 20
2024
|
Thomas P Carey Corporate VP |
SELL
Open market or private sale
|
Direct |
2,500
-21.08%
|
$500,000
$200.4 P/Share
|
|
May 10
2024
|
Richard John Stingi Corporate VP and CHRO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
400
-7.89%
|
$77,600
$194.03 P/Share
|
|
Apr 08
2024
|
Thomas P Carey Corporate VP |
SELL
Payment of exercise price or tax liability
|
Direct |
1,442
-10.84%
|
$291,284
$202.75 P/Share
|
|
Apr 05
2024
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
42
+0.19%
|
-
|
|
Apr 05
2024
|
Maura A. Markus Director |
BUY
Grant, award, or other acquisition
|
Direct |
65
+0.13%
|
-
|
|
Apr 05
2024
|
Eileen K Murray Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.15%
|
-
|